A detailed history of High Mark Wealth Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, High Mark Wealth Management LLC holds 79 shares of ABBV stock, worth $13,253. This represents 0.01% of its overall portfolio holdings.

Number of Shares
79
Previous 84 5.95%
Holding current value
$13,253
Previous $14,000 7.14%
% of portfolio
0.01%
Previous 0.01%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

SELL
$163.84 - $199.33 $819 - $996
-5 Reduced 5.95%
79 $15,000
Q2 2024

Jul 29, 2024

BUY
$154.79 - $180.76 $4,953 - $5,784
32 Added 61.54%
84 $14,000
Q1 2024

Apr 26, 2024

BUY
$159.82 - $182.1 $3,516 - $4,006
22 Added 73.33%
52 $9,000
Q4 2023

Jan 22, 2024

SELL
$137.6 - $154.97 $12,521 - $14,102
-91 Reduced 75.21%
30 $4,000
Q3 2023

Oct 18, 2023

BUY
$133.59 - $154.65 $14,026 - $16,238
105 Added 656.25%
121 $18,000
Q4 2022

Feb 01, 2023

SELL
$138.31 - $165.87 $5,117 - $6,137
-37 Reduced 69.81%
16 $2,000
Q3 2022

Oct 21, 2022

BUY
$134.21 - $153.93 $402 - $461
3 Added 6.0%
53 $7,000
Q2 2022

Jul 19, 2022

SELL
$137.62 - $174.96 $412 - $524
-3 Reduced 5.66%
50 $8,000
Q4 2021

Jan 20, 2022

BUY
$107.43 - $135.93 $322 - $407
3 Added 6.0%
53 $7,000
Q3 2021

Nov 01, 2021

BUY
$106.4 - $120.78 $851 - $966
8 Added 19.05%
50 $5,000
Q2 2021

Aug 02, 2021

BUY
$105.21 - $117.21 $105 - $117
1 Added 2.44%
42 $5,000
Q1 2021

Apr 22, 2021

BUY
$102.3 - $112.62 $4,194 - $4,617
41 New
41 $4,000
Q4 2020

Jan 27, 2021

SELL
$80.49 - $108.67 $13,361 - $18,039
-166 Closed
0 $0
Q3 2020

Oct 26, 2020

BUY
$85.91 - $100.83 $171 - $201
2 Added 1.22%
166 $15,000
Q2 2020

Jul 22, 2020

BUY
$73.37 - $98.18 $12,032 - $16,101
164 New
164 $16,000
Q1 2020

Apr 30, 2020

SELL
$64.5 - $97.79 $13,029 - $19,753
-202 Closed
0 $0
Q4 2019

Mar 19, 2020

BUY
$72.13 - $90.25 $14,570 - $18,230
202 New
202 $17,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $297B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track High Mark Wealth Management LLC Portfolio

Follow High Mark Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Mark Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Mark Wealth Management LLC with notifications on news.